- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/083 - Tripeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
Patent holdings for IPC class C07K 5/083
Total number of patents in this class: 669
10-year publication summary
|
58
|
60
|
49
|
50
|
30
|
43
|
52
|
34
|
29
|
37
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4797 |
20 |
| ImmunoGen, Inc. | 401 |
14 |
| Biohaven Therapeutics Ltd. | 113 |
11 |
| Onyx Therapeutics, Inc. | 68 |
10 |
| Agency for Science, Technology and Research | 3648 |
8 |
| Kyoto University | 2856 |
8 |
| Arvinas Operations, Inc. | 242 |
8 |
| Merck Sharp & Dohme LLC | 3735 |
8 |
| Hoffmann-La Roche Inc. | 3555 |
7 |
| Genentech, Inc. | 4005 |
7 |
| Supadelixir Inc. | 23 |
7 |
| Yafei Shanghai Biolog Medicine Science & Technology Co., Ltd. | 14 |
7 |
| DSM IP Assets B.V. | 5496 |
6 |
| Purdue Research Foundation | 3744 |
6 |
| Northwestern University | 3458 |
6 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2222 |
6 |
| Gilead Pharmasset LLC | 41 |
6 |
| New York University | 1779 |
6 |
| Trustees of Tufts College | 917 |
6 |
| viDA Therapeutics Inc. | 15 |
6 |
| Other owners | 506 |